1. Home
  2. STKS vs DXR Comparison

STKS vs DXR Comparison

Compare STKS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The ONE Group Hospitality Inc.

STKS

The ONE Group Hospitality Inc.

N/A

Current Price

$1.79

Market Cap

57.1M

ML Signal

N/A

Logo Daxor Corporation

DXR

Daxor Corporation

HOLD

Current Price

$10.75

Market Cap

57.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKS
DXR
Founded
2004
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
57.4M
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
STKS
DXR
Price
$1.79
$10.75
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.70
N/A
AVG Volume (30 Days)
35.6K
9.9K
Earning Date
05-04-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,722,000.00
$1,446,345.00
Revenue This Year
$7.47
$44,935.22
Revenue Next Year
$8.12
$74.79
P/E Ratio
N/A
$33.83
Revenue Growth
19.66
N/A
52 Week Low
$1.65
$7.10
52 Week High
$5.19
$14.76

Technical Indicators

Market Signals
Indicator
STKS
DXR
Relative Strength Index (RSI) 47.37 69.33
Support Level $1.67 $11.31
Resistance Level $2.03 $14.02
Average True Range (ATR) 0.08 0.45
MACD 0.01 0.28
Stochastic Oscillator 45.45 98.45

Price Performance

Historical Comparison
STKS
DXR

About STKS The ONE Group Hospitality Inc.

The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.

Share on Social Networks: